Diabetes Room

In this room you can find updates and expert discussions in diabetes.

Drug Safety Update: dapagliflozin (Forxiga) no longer authorised for treatment of type 1 diabetes mellitus

The authorisation holder for dapagliflozin has withdrawn the indication for type 1 diabetes mellitus. The removal of the type 1 diabetes indication is not due to any new safety concerns and the other indications of dapagliflozin are unchanged.
Go to the profile of OnMedica
Dec 10, 2021